349 related articles for article (PubMed ID: 34362389)
1. NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
Tao W; Tian G; Xu S; Li J; Zhang Z; Li J
Cancer Cell Int; 2021 Aug; 21(1):413. PubMed ID: 34362389
[TBL] [Abstract][Full Text] [Related]
2. Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway.
Guo Q; Yu W; Tan J; Zhang J; Chen J; Rao S; Guo X; Cai K
Cancer Med; 2024 Jun; 13(11):e7283. PubMed ID: 38826095
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of
Ma N; Liu H; Wu Y; Yao M; Zhang B
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743017
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer.
Wu J; Zhu H; Wu J; Chen W; Guan X
Am J Transl Res; 2018; 10(1):256-264. PubMed ID: 29423010
[TBL] [Abstract][Full Text] [Related]
6. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
[TBL] [Abstract][Full Text] [Related]
7. N-Acetyltransferase 10 Enhances Doxorubicin Resistance in Human Hepatocellular Carcinoma Cell Lines by Promoting the Epithelial-to-Mesenchymal Transition.
Zhang X; Chen J; Jiang S; He S; Bai Y; Zhu L; Ma R; Liang X
Oxid Med Cell Longev; 2019; 2019():7561879. PubMed ID: 31354912
[TBL] [Abstract][Full Text] [Related]
8. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
9. NAT10 promotes cell proliferation by acetylating
Wei R; Cui X; Min J; Lin Z; Zhou Y; Guo M; An X; Liu H; Janz S; Gu C; Wang H; Yang Y
Acta Pharm Sin B; 2022 Aug; 12(8):3313-3325. PubMed ID: 35967285
[TBL] [Abstract][Full Text] [Related]
10. Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
Tian G; Fu Y; Zhang D; Li J; Zhang Z; Yang X
Cancer Cell Int; 2021 Mar; 21(1):167. PubMed ID: 33712015
[TBL] [Abstract][Full Text] [Related]
11. NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration.
Xuan G; Zhang X; Zhang M; Yu M; Zhou Y; He X; Hu X; Wang X; Liu L
Front Oncol; 2022; 12():783919. PubMed ID: 35785175
[TBL] [Abstract][Full Text] [Related]
12. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
[TBL] [Abstract][Full Text] [Related]
13. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK/ERK signaling pathway.
Liu Y; Wang X; Liu Y; Yang J; Mao W; Feng C; Wu X; Chen X; Chen L; Dong P
Cell Death Dis; 2023 Nov; 14(11):712. PubMed ID: 37914704
[TBL] [Abstract][Full Text] [Related]
14. High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.
Lu T; Zheng Y; Gong X; Lv Q; Chen J; Tu Z; Lin S; Pan J; Guo Q; Li J
Front Oncol; 2021; 11():608842. PubMed ID: 33763352
[No Abstract] [Full Text] [Related]
15. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
16. AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling.
Fu L; Jin Q; Dong Q; Li Q
Onco Targets Ther; 2021; 14():5237-5248. PubMed ID: 34785906
[TBL] [Abstract][Full Text] [Related]
17. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation.
Shrimp JH; Jing Y; Gamage ST; Nelson KM; Han J; Bryson KM; Montgomery DC; Thomas JM; Nance KD; Sharma S; Fox SD; Andressen T; Sinclair WR; Wu H; Allali-Hassani A; Senisterra G; Vedadi M; Lafontaine D; Dahlin JL; Marmorstein R; Walters MA; Meier JL
ACS Med Chem Lett; 2021 Jun; 12(6):887-892. PubMed ID: 34141066
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a m
Zhao X; Cui L
Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
[No Abstract] [Full Text] [Related]
20. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression.
Liu Z; Liu X; Li Y; Ren P; Zhang C; Wang L; Du X; Xing B
Cancer Manag Res; 2019; 11():5317-5332. PubMed ID: 31239781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
